Vitamin market mostly calm

In partnership with Feed Additive Prices

Vitamin A1000 has kept stable, and so has vitamin D3, B5 and B3. Most vitamins are quiet in terms of trading activity and/or price swings.

Vitamin E 50%

After a period of slightly firmer markets, things look more stable now and prices are not firming anymore and in some regions are even slightly weaker compared to some weeks ago. A decent cover was already taken in the previous weeks, so not a lot of new additional demand is seen currently. Most of Q2 is contracted and some cover into Q3 is seen as well.

Vitamin A 1000

No changes are seen in the market compared to the previous weeks. The market is relatively quiet and prices seem stable in most regions at the moment. A portion of Q2 has been contracted.

Vitamin D3 500

It is a quiet market and no significant changes are seen, compared to previous weeks. Local stock levels remain relatively low, but at the same time, any significant new demand is also not seen. Prices are stable in most regions, at a relatively low level. Q2 is partly contracted as buyers saw limited further price decline potential.

Vitamin B2 80%

There were/are some attempts by manufacturers and suppliers to increase prices but without any effect. The vitamin B2 market remains very quiet and stable. Prices in Asia are still relatively low, while prices in Europe and the US are higher and stable, compared to that. A portion of Q2 is contracted.

D-Calpan

An ongoing quiet and stable market. There still seems to be ample supply with relatively low new demand in most regions. The price decline has stopped for some weeks already and the market seemed to have bottomed out at a very low level. Already a decent cover ahead is taken into Q2.

Vitamin B3

Until last week, the market atmosphere was a bit firmer but that seemed to have faded away again. Suppliers were trying to increase prices due to higher raw material costs. But at the same time, some suppliers also want to keep a certain market share and have kept their prices stable. Availability seems to be good in most regions. There was already some cover taken into Q2 some time ago when prices stabilised at a low level.

Biotin

Some firmer price offers were seen, but no effect from that so far on actual transactions as there is ample supply, and long-term contracts were already concluded some time ago in most cases and regions. Prices remain historically low. A good portion of Q2 is contracted and some of Q3 as well. In some cases, buyers took long-term contracts well into 2024.

Vitamin C 35% mono

Prices are still holding up at a higher level compared to last year. There even seems to be a slightly firmer tone in current price offers FOB China and the local regions. Actual significant market transactions are not seen or reported though. Until now, no change in strategy from suppliers to keep prices up and increase them even further. Most buyers took long-term contracts when the price was low or when it started to increase. Q2 is largely contracted and in some cases, a large portion of 2024 as well.